This HTML5 document contains 31 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73907423
rdf:type
wikibase:Item
schema:description
scientific article published on 01 June 2000 наукова стаття, опублікована в червні 2000 im Juni 2000 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en xunu de 2000 wetenschappelijk artikel
p:P577
wds:Q73907423-53D3600B-B743-49CF-9116-296808F12509
wdt:P577
2000-06-01T00:00:00Z
p:P407
wds:Q73907423-FE51E76A-370F-4DD8-A4C7-6D2D549FEFC1
wdt:P407
wd:Q1860
rdfs:label
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group
skos:prefLabel
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department
schema:name
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department
p:P1476
wds:Q73907423-3270C5F5-2C94-4C7B-93D4-33386564E82C
wdt:P1476
Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group
p:P304
wds:Q73907423-9AC66C49-9709-4C81-B922-2823BC583419
wdt:P304
2788-2794
p:P31
wds:Q73907423-96D5F23D-611B-4CF5-A433-85A599A874AC
wdt:P31
wd:Q13442814
p:P698
wds:Q73907423-9A93E66C-9BEC-427D-902D-8F60B3891D42
wdtn:P698
n11:10859283
wdt:P698
10859283
p:P1433
wds:Q73907423-83518657-6F68-422E-A5D3-F474FF321906
wdt:P1433
wd:Q578091
p:P433
wds:Q73907423-3705AEFC-80DE-44AA-9CB3-F4CD243B1557
p:P478
wds:Q73907423-B42B9B0B-D312-4899-8430-4FC0A74DE08C
wdt:P433
24
wdt:P478
101